0001104659-24-089794.txt : 20240814
0001104659-24-089794.hdr.sgml : 20240814
20240814192837
ACCESSION NUMBER: 0001104659-24-089794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240814
FILED AS OF DATE: 20240814
DATE AS OF CHANGE: 20240814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYTLE PAUL J
CENTRAL INDEX KEY: 0001244110
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42139
FILM NUMBER: 241210170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACTUATE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001652935
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473044785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1751 RIVER RUN
STREET 2: SUITE 400
CITY: FORT WORTH
STATE: TX
ZIP: 76107
BUSINESS PHONE: 847-986-4190
MAIL ADDRESS:
STREET 1: 1751 RIVER RUN
STREET 2: SUITE 400
CITY: FORT WORTH
STATE: TX
ZIP: 76107
FORMER COMPANY:
FORMER CONFORMED NAME: Apotheca Therapeutics, Inc.
DATE OF NAME CHANGE: 20150911
4
1
tm2421559-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-08-14
0
0001652935
ACTUATE THERAPEUTICS, INC.
ACTU
0001244110
LYTLE PAUL J
C/O ACTUATE THERAPEUTICS, INC.
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
0
1
0
0
Chief Financial Officer
0
Non-Qualified Stock Options
8.00
2024-08-14
4
A
0
234971
0
A
2034-08-14
Common Stock
234971
0
D
234,971 stock options granted upon the closing of the issuer's initial public offering on August 14, 2024, 25% of which vest on June 1, 2025 and the remaining 75% of which vest in equal monthly installments during the 36 months following June 1, 2025.
/s/ Paul Lytle
2024-08-14